EDITORIAL
Published on 14 Jul 2023
Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
doi 10.3389/fonc.2023.1220063
- 1,233 views
- 2 citations
- Frontiers in Oncology
- Neuro-Oncology and Neurosurgical Oncology
- Research Topics
- Metabolic Reprogramming for Acquiring Therapeutic Resistance in Glioblastoma
Metabolic Reprogramming for Acquiring Therapeutic Resistance in Glioblastoma
8,366
Total downloads
30k
Total views and downloads
Articles
REVIEW
Published on 26 Apr 2023
An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?
doi 10.3389/fonc.2023.1166207
- 12,257 views
- 36 citations
ORIGINAL RESEARCH
Published on 20 Feb 2023
Flavin fluorescence lifetime and autofluorescence optical redox ratio for improved visualization and classification of brain tumors
doi 10.3389/fonc.2023.1105648
- 2,725 views
- 12 citations
ORIGINAL RESEARCH
Published on 20 Jan 2023
Multiomics integration reveals the effect of Orexin A on glioblastoma
doi 10.3389/fphar.2023.1096159
- 2,627 views
- 7 citations
MINI REVIEW
Published on 20 Dec 2022
Succinylation and redox status in cancer cells
doi 10.3389/fonc.2022.1081712
- 5,775 views
- 25 citations
Published in
Frontiers in Oncology
Neuro-Oncology and Neurosurgical Oncology
Pharmacology of Anti-Cancer Drugs
Molecular and Cellular Oncology
Participating Journals
Frontiers in Neurology
- 2.8 impact factor
- 5.2 citescore
Frontiers in Pharmacology
- 4.8 impact factor
- 8.9 citescore